Covered recipient · General Payments record
SHIBAN K RAINA
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$2,480.08
- Reported across 148 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $614.42 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $322.45 | 22 |
| Madrigal Pharmaceuticals | $62.13 | 2 |
| Celgene Corporation | $54.92 | 2 |
| Gilead Sciences, Inc. | $50.85 | 3 |
| GENZYME CORPORATION | $40.16 | 2 |
| Janssen Biotech, Inc. | $29.43 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $23.79 | 1 |
| EVOKE PHARMA, INC. | $15.59 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $15.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.90 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105354671 | CMS |
| ABBVIE INC. | $22.84 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105354675 | CMS |
| ABBVIE INC. | $1.61 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105354678 | CMS |
| ABBVIE INC. | $17.85 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105354682 | CMS |
| ABBVIE INC. | $22.90 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105354687 | CMS |
| ABBVIE INC. | $20.32 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105354691 | CMS |
| ABBVIE INC. | $2.01 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105354694 | CMS |
| ABBVIE INC. | $17.82 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105354699 | CMS |
| ABBVIE INC. | $16.44 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105354702 | CMS |
| ABBVIE INC. | $1.41 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105354707 | CMS |
| ABBVIE INC. | $0.55 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105354711 | CMS |
| ABBVIE INC. | $19.19 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105354715 | CMS |
| ABBVIE INC. | $19.11 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105354719 | CMS |
| ABBVIE INC. | $25.55 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105354723 | CMS |
| ABBVIE INC. | $16.48 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105354727 | CMS |
| ABBVIE INC. | $25.28 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105354731 | CMS |
| ABBVIE INC. | $17.45 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105354735 | CMS |
| ABBVIE INC. | $16.41 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105354739 | CMS |
| ABBVIE INC. | $2.69 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105354743 | CMS |
| ABBVIE INC. | $23.20 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105354747 | CMS |
| ABBVIE INC. | $1.61 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105354751 | CMS |
| ABBVIE INC. | $17.83 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105354755 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $15.10 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147019064 | CMS |
| Celgene Corporation | $29.34 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101114688 | CMS |
| Celgene Corporation | $25.58 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101114690 | CMS |
| EVOKE PHARMA, INC. | $15.59 | 12/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127780761 | CMS |
| GENZYME CORPORATION | $21.55 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139934271 | CMS |
| GENZYME CORPORATION | $18.61 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139934395 | CMS |
| Gilead Sciences, Inc. | $17.75 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133775879 | CMS |
| Gilead Sciences, Inc. | $13.78 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133775881 | CMS |
| Gilead Sciences, Inc. | $19.32 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133775883 | CMS |
| Intercept Pharmaceuticals, Inc. | $23.79 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113642761 | CMS |
| Janssen Biotech, Inc. | $29.43 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078581326 | CMS |
| Madrigal Pharmaceuticals | $30.80 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144179685 | CMS |
| Madrigal Pharmaceuticals | $31.33 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144179687 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.